Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Akero Therapeutics Q2 EPS $(0.77) Up From $(0.83) YoY

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.77) per share. This is a 7.23 percent increase over losses of $(0.83) per share from the same period last year.
byBenzinga Newsdesk
August 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.77) per share. This is a 7.23 percent increase over losses of $(0.83) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For First Bancshares

By Benzinga Insights
July 26, 3:26 PM
First Bancshares (NASDAQ:FBMS) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that First Bancshares will report an earnings per share (EPS) of $0.81.

FBMS